Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierangelo Geppetti

Showing results (131-140 of 227) with videos related to

Pageof 23
Sort By:
Headache|July 16, 2024
Impact of duration of chronic migraine on long-term effectiveness of monoclonal antibodies targeting the calcitonin gene-related peptide pathway-A real-world studyRaffaele Ornello, Francesca Baldini, Agnese Onofri, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
British Journal of Pharmacology|August 19, 2003
Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonistsGiovanni Appendino, Selena Harrison, Luciano De Petrocellis, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 22, 2020
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort studySilvia Benemei, Chiara Lupi, Francesco De Cesaris, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patientsLuca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al.
The Journal of Headache and Pain|January 9, 2019
Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|December 20, 2018
Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
The Journal of Headache and Pain|October 21, 2018
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 2, 2018
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airwayFabien Schmidlin, Silvia Amadesi, Karim Dabbagh, et al.
Pageof 23

Showing results (131-140 of 227) with videos related to

Sort By:
Pageof 23
Headache|July 16, 2024
Impact of duration of chronic migraine on long-term effectiveness of monoclonal antibodies targeting the calcitonin gene-related peptide pathway-A real-world studyRaffaele Ornello, Francesca Baldini, Agnese Onofri, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
British Journal of Pharmacology|August 19, 2003
Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonistsGiovanni Appendino, Selena Harrison, Luciano De Petrocellis, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 22, 2020
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort studySilvia Benemei, Chiara Lupi, Francesco De Cesaris, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patientsLuca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al.
The Journal of Headache and Pain|January 9, 2019
Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|December 20, 2018
Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
The Journal of Headache and Pain|October 21, 2018
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 2, 2018
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airwayFabien Schmidlin, Silvia Amadesi, Karim Dabbagh, et al.
Pageof 23